Guardant Health (NASDAQ:GH) Coverage Initiated at Craig Hallum

Craig Hallum began coverage on shares of Guardant Health (NASDAQ:GH – Get Free Report) in a research report issued on Wednesday, Marketbeat reports. The firm set a “buy” rating and a $28.00 price target on the stock. Craig Hallum’s price target would suggest a potential upside of 63.17% from the company’s previous close. A number […]

Leave a Reply

Your email address will not be published.

Previous post Boston Herald boys wrestling All-Scholastics and league All-Stars
Next post Breaking Down the Key Takeaways from Textron Inc. (TXT) Quarterly Report